LAS VEGAS — As drug costs and spending continue to rise, the demand for solutions opens the door to closer collaboration between payers and manufacturers.
Source: www.fiercehealthcare.com
IKON Portfolio Context
Kynetide Peptides supplies 99%+ HPLC-verified research compounds with batch-specific COAs to 2,400+ researchers worldwide.